Kineret - Anakinra - Dosage - Side Effects - Interactions - Warnings
Kineret (anakinra) drug information, dosage, side effects, drug interactions, and warnings. Kineret, generic drug name anakinra, is a biologic response modifier used in the treatment of arthritis. Kineret (anakinra) inhibits the action of the molecule interleukin-1.
Drug Monograph: Kineret / Anakinra / Kineret Solution
Anakinra (Kineret) is a recombinant, nonglycosylated form of the human interleukin-1 receptor antagonist (IL-1Ra). Anakinra is given subcutaneously.
Anakinra (Kineret) is a recombinant, nonglycosylated form of the human interleukin-1 receptor antagonist (IL-1Ra). Anakinra is given subcutaneously.
Patient Education: Kineret / Anakinra Injection
Patient education for Kineret / anakinra injection.
Patient education for Kineret / anakinra injection.
Product Photographs: Kineret / Anakinra
Product photographs of Kineret / Anakinra.
Product photographs of Kineret / Anakinra.
Biologic Drugs - Are Some Arthritis Patients Unsuitable Candidates For Biologic Drugs?
The medical history of some arthritis patients make them unsuitable candidates for biologic drugs such as Enbrel, Remicade, Humira, Orencia, and Rituxan.
The medical history of some arthritis patients make them unsuitable candidates for biologic drugs such as Enbrel, Remicade, Humira, Orencia, and Rituxan.
Arthritis Drugs: What Are My Options?
Medications have long been considered "traditional" treatment. Since individual response to a specific medication can vary and because possible side effects are also a factor, finding the most effective medication or combination of medications can be a more difficult process than one would expect.
Medications have long been considered "traditional" treatment. Since individual response to a specific medication can vary and because possible side effects are also a factor, finding the most effective medication or combination of medications can be a more difficult process than one would expect.
11/18/2001 Kineret History: Kineret (Anakinra) Approved By FDA
11/18/2001, FDA approves Kineret (anakinra) for rheumatoid arthritis patients who have failed DMARDs.
11/18/2001, FDA approves Kineret (anakinra) for rheumatoid arthritis patients who have failed DMARDs.
08/19/2001 Kineret History: Kineret Recommended For FDA Approval
8/19/2001, FDA Arthritis Advisory Committee voted to recommend Kineret (anakinra) for approval.
8/19/2001, FDA Arthritis Advisory Committee voted to recommend Kineret (anakinra) for approval.
06/18/2001 Kineret History: Anakinra / Pegsunercept (PEG sTNF-R1)
06/18/2001, Amgen presents study data for Anakinra (Kineret) and Pegsunercept (PEG sTNF-R1).
06/18/2001, Amgen presents study data for Anakinra (Kineret) and Pegsunercept (PEG sTNF-R1).
Patient Information: Kineret / Anakinra
Information for patients from Amgen the makers of Kineret (Anakinra).
Information for patients from Amgen the makers of Kineret (Anakinra).
Amgen’s Patient Assistance: Kineret (Anakinra)
Amgen’s patient assistance programs provide replacement product for qualifying patients who are uninsured or underinsured with limited financial resources.
Amgen’s patient assistance programs provide replacement product for qualifying patients who are uninsured or underinsured with limited financial resources.